Journal of Innovation in Cardiac Rhythm Management
banner AtriCure HRS2024

 

Activity Description

The enduring on-demand archive presents the full proceedings of a CME lunch symposium held at Heart Rhythm 2024, which features leading experts who examine the latest clinical trial data and real-world experiences of transformational treatment strategies and evaluate their potential impact on daily practice.

 

Agenda

tmb AtriCure HRS2024 Panel  

Access On-Demand Webinar

 

Claiming Credit:
To earn credit upon viewing the video; access the CME Accreditation tab >>, click on the Claim Credit Button, and complete the post-activity CME test. This activity provides 1.5 AMA PRA Category 1 Credits™ for Physicians and 1.5 Contact Hours for Nurses.

Agenda

Welcome and Introductions
Devi Nair, MD

LeAAPS Clinical Trial
Richard Whitlock, MD, PhD

CONVERGE Post-Approval Study
David DeLurgio, MD

DEEP Pivotal Study 
Kenneth Ellenbogen, MD

HEAL-IST Study
Dhanunjaya Lakkireddy, MD

Panel Discussion with Q&A
Moderator: Devi Nair, MD
Panelists: Kenneth Ellenbogen, MD, David DeLurgio, MD, Dhanunjaya Lakkireddy, MD, and Richard Whitlock, MD, PhD  

Commercial Support
The activity is supported through an educational grant from AtriCure, Inc.

Joint Providership:
MediaSphere Medical, LLC and Ciné-Med

 

Faculty

Program Chair and Moderator
Devi Nair MD

Devi Nair, MD, FACC, FHRS
Director of the Cardiac Electrophysiology Division
St. Bernard’s Heart & Vascular Center
Jonesboro, AR

Presenters and Panelists

David DeLurgio MD

David DeLurgio, MD, FACC, FHRS
Professor of Medicine; Emory University School of Medicine
Director of Electrophysiology; Emory St. Joseph’s Hospital
Atlanta, GA
Kenneth Ellenbogen MD

Kenneth Ellenbogen, MD, FHRS
Martha M. and Harold W. Kimmerling Professor of Cardiology
Director Electrophysiology and Pacing
VCU School of Medicine
Richmond, VA
Dhanunjaya Lakkireddy MD

Dhanunjaya Lakkireddy, MD, FACC, FHRS  
Executive Medical Director
Kansas City Heart Rhythm Institute at HCA Midwest Health
Overland Park, KS
Richard Whitlock MD

Richard Whitlock, MD, PhD
Professor, Surgery
McMaster University
Hamilton, Ontario, Canada
   

CME Accreditation

CME Released: 6/7/2024; Valid for credit through 6/7/2025

CME Certificate Fulfillment
To earn credit successfully, participants must complete the activity online during the valid credit period noted above. To receive CME Credits or Contact Hours, you must receive a minimum score of 70% on the post-test, accessible through the Claim Credit Button. Certificates are issued via email upon successful completion.

Target Audience
The symposium is intended to meet the educational needs of Electrophysiologists, Cardiologists, Cardiac and Cardiothoracic Surgeons, Fellows-in-Training, and Allied Healthcare Professionals with a clinical focus of cardiac arrhythmia and left atrial appendage management.  

Learning Objectives
Upon completion of this educational activity, participants will be able to:

  • Assess the safety and efficacy of LAA exclusion for the prevention of ischemic stroke or systemic arterial embolism in cardiac surgery patients without Afib, who are at elevated risk for these events.
  • Examine the role of sinus node sparing hybrid ablation for the treatment of drug-refractory patients with Inappropriate Sinus Tachycardia (IST).
  • Discuss the safety and efficacy of Hybrid Convergent ablation for the treatment of symptomatic longstanding persistent AF who are refractory or intolerant to AADs.
  • Assess the safety and efficacy of dual epicardial and endocardial ablation in a cohort of patients presented with persistent or longstanding persistent AF.

Accreditation Statement
Jointly Accredited Provider TMTo support the improvement of patient care, this activity has been planned and implemented by MediaSphere Medical and Ciné-Med. Ciné-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health-care team.

Ciné-Med designates this educational activity for a maximum of 1.5 AMA PRA CATEGORY 1 Credit(s)™ for Physicians. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Ciné-Med designates this activity for 1.5 Contact Hours for Nurses.

Disclosure Policy
MediaSphere Medical and Ciné-Med adheres to accreditation requirements concerning industry support of continuing medical education. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. Speakers will disclose any relationships at the beginning of their presentations.

All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.

It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.

MediaSphere Medical and Ciné-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Non-Endorsement Statement
MediaSphere Medical and Ciné-Med verify that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.

Commercial Support
The activity is supported through an educational grant from AtriCure, Inc.

Joint Providership:
MediaSphere Medical, LLC and Ciné-Med

 

Claim CME

CME/CE Test
  1. Please complete the following CME/CE post-test. Your submission will be reviewed and notification provided shortly regarding certificate fulfillment status. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

  2. First Name: *  
    Invalid Input
  3. Last Name: *  
    Invalid Input
  4. Primary Email Address: *  
    Invalid Input
  5. Confirm Your Email: *  
    Invalid Input
  6. Degree: *  
    Invalid Input
  7. Specialty:*  
    Invalid Input
  8. Institution: *  
    Invalid Input
  9. Mailing Address:*  
    Invalid Input
  10. City: *  
    Invalid Input
  11. State: *  
    Invalid Input

  12. 1) When evaluating Precursor Trials and Rationale for LAA Exclusion, the LAAOS III Trial demonstrated significantly better outcomes among patients with pre-existing AF who underwent cardiac surgery with LAA occlusion.
  13. Select one*  


    Invalid Input Please Select one

  14. 2) Which statement is accurate regarding key takeaways from the CONVERGE Post-Approval Study?
  15. Select one*  







    Invalid Input Please Select one

  16. 3) Hybrid ablation is highly successful at controlling AF for up to 2 years despite long durations of AF and large LA. It is associated with a low complication rate similar to catheter ablation and improves quality of life. It particularly has a role in long-standing PSFA, large LA, and perhaps redo AF ablations where epicardial sparring may be pro-arrhythmic.
  17. Select one*  


    Invalid Input Please Select one

  18. Although optional, we respectfully request that you complete the activity evaluation form, since your feedback assists in the development of future educational activities.

  19. Background

    Please rate each question using a scale of 1 to 5 (1 = Beginner, 5 = Advanced)


  20. I would consider my level of expertise in the subject matter prior to the webcast as:
    Invalid Input Please Select one

  21. I would consider my level of expertise in the subject matter after the activity:
    Invalid Input

  22. Considering my experience and background, the material presented was:
    Invalid Input Please Select one

  23. Extent to which activity met the identified objectives
    Please rate each question using a scale of 1 to 5 (1 = Not Met, 5 = Completely Met)

  24. Assess the safety and efficacy of LAA exclusion for the prevention of ischemic stroke or systemic arterial embolism in cardiac surgery patients without Afib, who are at elevated risk for these events.
    Invalid Input Please Select one

  25. Examine the role of sinus node-sparing hybrid ablation in treating drug-refractory patients with Inappropriate Sinus Tachycardia (IST).
    Invalid Input Please Select one

  26. Discuss the safety and efficacy of Hybrid Convergent ablation for the treatment of symptomatic longstanding persistent AF who are refractory or intolerant to AADs.
    Invalid Input Please Select one

  27. Assess the safety and efficacy of dual epicardial and endocardial ablation in a cohort of patients presented with persistent or longstanding persistent AF.
    Invalid Input

  28. Information Presented
    Please evaluate the information that was presented by answering Yes, No, Maybe or Not Applicable

  29. Reinforced my current practice/treatment habits:
    Invalid Input Please Select one

  30. Will improve my practice/patient outcomes:
    Invalid Input Please Select one

  31. Enhanced my current knowledge base:
    Invalid Input Please Select one

  32. Provided new ideas or information that I expect to use:
    Invalid Input Please Select one

  33. Information gained from this conference will result in making a change in your practice:
    Invalid Input Please Select one

  34. Future activities on this subject matter is important to my practice:
    Invalid Input Please Select one

  35. Addressed a professional practice gap:
    Invalid Input Please Select one

  36. Was free of commercial bias/influence:
    Invalid Input Please Select one

  37. What barriers do you anticipate in incorporating best practices learned in this activity into clinical activities or quality improvement initiatives at your institution?
    Invalid Input

  38. What mechanisms can you identify to overcome these barriers?
    Invalid Input

  39. (*) Required Fields
  40. Invalid Input

Editorial Board | Author Guidelines | About Us | Contact Us | Submit Manuscript | Subscribe | Terms of Use | Privacy Policy

505 South Lenola Road, Suite 121, Moorestown, NJ 08057

  Copyright © 2011-2024  MediaSphere Medical LLC.  All Rights Reserved.   

Website Design Internet Marketing by DigitalSequence